SG10201703071YA - Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin - Google Patents

Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin

Info

Publication number: SG10201703071YA
Authority: SG; Singapore
Prior art keywords: rejeuvenation; oxidatitive; allantoin; glucosamine; composition
Prior art date: 2008-11-07

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-11-06Application filed by Klox Tech IncfiledCriticalKlox Tech Inc

2017-06-29Publication of SG10201703071YApublicationCriticalpatent/SG10201703071YA/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/22—Peroxides; Oxygen; Ozone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
- A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0616—Skin treatment other than tanning
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/14—Preparations for removing make-up
- A61Q1/145—Tattoo removal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
- A61N2005/0663—Coloured light

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Birds (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Pathology (AREA)
Radiology & Medical Imaging (AREA)
Emergency Medicine (AREA)
Botany (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gerontology & Geriatric Medicine (AREA)
Dispersion Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Physiology (AREA)
Developmental Biology & Embryology (AREA)
Environmental Sciences (AREA)
Medicines Containing Plant Substances (AREA)
Biotechnology (AREA)

SG10201703071YA2008-11-072009-11-06Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoinSG10201703071YA (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US11223508P	2008-11-07	2008-11-07

Publications (1)

Publication Number	Publication Date
SG10201703071YAtrue SG10201703071YA (en)	2017-06-29

Family

ID=42152429

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SG10201703078QASG10201703078QA (en)	2008-11-07	2009-11-06	Combination of an oxidant and a photoactivator for the healing of wounds
SG10201703071YASG10201703071YA (en)	2008-11-07	2009-11-06	Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
SG10201703078QASG10201703078QA (en)	2008-11-07	2009-11-06	Combination of an oxidant and a photoactivator for the healing of wounds

Country Status (25)

Country	Link
US (14)	US8658219B2 (en)
EP (4)	EP2352488B1 (en)
JP (10)	JP5478631B2 (en)
KR (5)	KR20170141807A (en)
CN (4)	CN102256591B (en)
AU (2)	AU2009311239B2 (en)
BR (2)	BRPI0921269A2 (en)
CA (4)	CA2936527C (en)
CY (2)	CY1118716T1 (en)
DK (3)	DK2365829T3 (en)
EA (5)	EA201792479A3 (en)
ES (3)	ES2618802T3 (en)
HK (1)	HK1211478A1 (en)
HR (3)	HRP20171022T1 (en)
HU (2)	HUE045950T2 (en)
IL (4)	IL212559A (en)
LT (2)	LT2365829T (en)
MX (3)	MX339255B (en)
NZ (5)	NZ631218A (en)
PL (3)	PL2352488T3 (en)
PT (3)	PT2352488T (en)
SG (2)	SG10201703078QA (en)
SI (2)	SI2365829T1 (en)
SM (2)	SMT201700335T1 (en)
WO (2)	WO2010051636A1 (en)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2861734B1 (en)	2003-04-10	2006-04-14	Corneal Ind	CROSSLINKING OF LOW AND HIGH MOLECULAR MASS POLYSACCHARIDES; PREPARATION OF INJECTABLE SINGLE PHASE HYDROGELS; POLYSACCHARIDES AND HYDROGELS OBTAINED
CA2966261A1 (en)	2005-11-09	2007-07-19	Klox Technologies Inc.	Teeth whitening compositions and methods
US20100266989A1 (en)*	2006-11-09	2010-10-21	Klox Technologies Inc.	Teeth whitening compositions and methods
EP3498299A1 (en)	2007-11-16	2019-06-19	Aclaris Therapeutics, Inc.	Compositions and methods for treating purpura
US8394782B2 (en)	2007-11-30	2013-03-12	Allergan, Inc.	Polysaccharide gel formulation having increased longevity
US8357795B2 (en)	2008-08-04	2013-01-22	Allergan, Inc.	Hyaluronic acid-based gels including lidocaine
ES2829971T3 (en)	2008-09-02	2021-06-02	Tautona Group Lp	Hyaluronic acid threads and / or derivatives thereof, methods to manufacture them and uses thereof
DK2365829T3 (en)	2008-11-07	2017-07-31	Klox Tech Inc	COMBINATION OF AN OXIDANT AND PHOTO ACTIVATOR FOR HEALING OF WOES
AU2014203119B2 (en)*	2009-07-17	2016-06-09	Klox Technologies Inc.	Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease
MX346003B (en)	2009-07-17	2017-03-01	Klox Tech Inc *	Antibacterial oral composition.
US9114188B2 (en)	2010-01-13	2015-08-25	Allergan, Industrie, S.A.S.	Stable hydrogel compositions including additives
US20110172180A1 (en)	2010-01-13	2011-07-14	Allergan Industrie. Sas	Heat stable hyaluronic acid compositions for dermatological use
EP2544652A2 (en)	2010-03-12	2013-01-16	Allergan Industrie SAS	A fluid composition comprising a hyaluronan polymer and mannitol for improving skin condition.
PL2550027T5 (en)	2010-03-22	2019-07-31	Allergan, Inc.	Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
US8883139B2 (en)	2010-08-19	2014-11-11	Allergan Inc.	Compositions and soft tissue replacement methods
US8889123B2 (en)	2010-08-19	2014-11-18	Allergan, Inc.	Compositions and soft tissue replacement methods
US9005605B2 (en)	2010-08-19	2015-04-14	Allergan, Inc.	Compositions and soft tissue replacement methods
US9408797B2 (en)	2011-06-03	2016-08-09	Allergan, Inc.	Dermal filler compositions for fine line treatment
US20130096081A1 (en)	2011-06-03	2013-04-18	Allergan, Inc.	Dermal filler compositions
US9393263B2 (en)	2011-06-03	2016-07-19	Allergan, Inc.	Dermal filler compositions including antioxidants
KR102154944B1 (en)	2011-06-03	2020-09-11	알러간 인더스트리 에스에이에스	Dermal filler compositions including antioxidants
US9662422B2 (en)	2011-09-06	2017-05-30	Allergan, Inc.	Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en)	2011-09-06	2013-09-19	Allergan, Inc.	Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US20130281913A1 (en)	2012-04-20	2013-10-24	Klox Technologies Inc.	Biophotonic compositions and methods for providing biophotonic treatment
US11116841B2 (en)	2012-04-20	2021-09-14	Klox Technologies Inc.	Biophotonic compositions, kits and methods
US10549112B2 (en)	2012-07-20	2020-02-04	The General Hospital Corporation	Apparatus for tissue irradiation and methods and kits utilizing the same
WO2015009992A1 (en)	2013-07-18	2015-01-22	The General Hospital Corporation	Vessel treatment systems, methods, and kits
WO2014015274A1 (en)	2012-07-20	2014-01-23	The General Hospital Corporation	Methods for tissue passivation
HK1212591A1 (en)*	2012-09-14	2016-06-17	Klox Technologies Inc.	Cosmetic biophotonic compositions
IN2015DN02938A (en)*	2012-09-14	2015-09-18	Klox Technologies Inc
WO2014042936A2 (en)	2012-09-14	2014-03-20	Valeant Pharmaceuticals International, Inc.	Compositions and methods for teeth whitening
JP6116842B2 (en)*	2012-09-25	2017-04-19	国立大学法人東京大学	Target cell specific photosensitizing compound.
US20140276354A1 (en)*	2013-03-14	2014-09-18	Klox Technologies Inc.	Biophotonic materials and uses thereof
CN103432581A (en)*	2013-03-22	2013-12-11	北京海思威科技有限公司	Application of carbamide peroxide injection in inactivation of viruses for treating diseases
CN107076724B (en)*	2013-03-29	2020-03-03	国立大学法人三重大学	Biological stain
WO2014190129A1 (en)	2013-05-24	2014-11-27	The Procter & Gamble Company	Low ph detergent composition
WO2015000058A1 (en)*	2013-07-03	2015-01-08	Klox Technologies Inc.	Biophotonic compositions comprising a chromophore and a gelling agent for treating wounds
EP3065699A1 (en)*	2013-11-05	2016-09-14	Nestec S.A.	Use of glucosamine-enriched plant compositions
KR20160140716A (en)*	2014-04-01	2016-12-07	클록스 테크놀로지스 인크.	Tissue filler compositions and methods of use
WO2015189712A2 (en)	2014-06-09	2015-12-17	Klox Technologies Inc.	Silicone-based biophotonic compositions and uses thereof
AR100864A1 (en)*	2014-06-09	2016-11-09	Klox Tech Inc	THERMOENDURECIBLE BIOPHOTONIC COMPOSITIONS AND THEIR USES
EP3160510A4 (en)*	2014-06-24	2018-02-21	Klox Technologies Inc.	Biophotonic compositions comprising halogen and uses thereof
EP3160440B1 (en)*	2014-06-30	2021-10-27	NUTRICOS Technologies	Combination products and cosmetic compositions for controlling skin disorders and skin aging that affect keratinocytes and/or fibroblasts and the dermis
EP3169400A4 (en)*	2014-07-18	2018-04-11	Dabney, Paul	Medical and veterinary applications of light to therapeutic compounds
US10016456B2 (en)*	2014-07-18	2018-07-10	Dabney Patents, L.L.C.	Methods for treating acne vulgaris
EP3620184A1 (en)	2014-09-30	2020-03-11	Allergan Industrie, SAS	Stable hydrogel compositions including additives
MX380590B (en)	2014-10-31	2025-03-12	Klox Tech Inc	PHOTOACTIVATABLE FABRIC AND FIBER MATERIALS.
WO2016128783A1 (en)	2015-02-09	2016-08-18	Allergan Industrie Sas	Compositions and methods for improving skin appearance
AU2016217792B2 (en)	2015-02-13	2020-07-02	Allergan Industrie, Sas	Implants for sculpting, augmenting or correcting facial features such as the chin
CN105031649A (en)*	2015-08-27	2015-11-11	厦门大学	Doped self-assembled nano fiber structure and preparation method thereof
AU2016343669A1 (en)*	2015-10-30	2018-05-10	Dabney Patents, L.L.C.	System, apparatus, and method of providing tattoo fading and removal
CN105342915A (en)*	2015-11-19	2016-02-24	山东朱氏堂医疗器械有限公司	Photon condensing gel and preparation method thereof
EP3402523A4 (en)*	2016-01-11	2019-07-24	Francesco Bellini	BIOPHOTONIC COMPOSITIONS FOR THE TREATMENT OF PYODERMITY
CA3011156A1 (en)*	2016-01-11	2017-07-20	Klox Technologies Limited	Biophotonic compositions for the treatment of otitis externa
BR112018014161A2 (en)*	2016-01-11	2018-12-11	Klox Tech Limited	biophotonic compositions for treating skin and soft tissue injury having one or both resistant and non-resistant infections
CN107837209A (en)*	2016-09-21	2018-03-27	张黎	A kind of seamless cleaning fluid of sewing
US11207408B2 (en)	2016-09-23	2021-12-28	Klox Technologies Inc.	Biophotonic compositions, methods, and kits for inhibiting and disrupting biofilms
JP2018048100A (en)*	2016-09-23	2018-03-29	クロクステクノロジーズインコーポレイテッド	Biophoton compositions, methods and kits for pain relief
US11953493B2 (en)	2017-02-08	2024-04-09	Fle International S.R.L.	Biophotonic methods for increasing in situ energy production and energy emission in biological cells and tissues
WO2018156807A1 (en)*	2017-02-22	2018-08-30	The General Hospital Corporation	Methods of photochemical treatment for wound healing
WO2019095072A1 (en)*	2017-11-17	2019-05-23	Klox Technologies Limited	Biophotonic compositions, methods and kits for enhancing hair growth
RU2699362C2 (en)*	2018-01-16	2019-09-05	ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НОВАСКИН" (ООО "Новаскин")	Composition based on cerium dioxide nanoparticles and brown algae polysaccharides for treating wounds
KR102012581B1 (en)*	2018-01-22	2019-08-20	주식회사 디알나노	Patch-type wound dressing comprising methylene blue mixture for treating skin wound
US10967197B2 (en)	2018-08-29	2021-04-06	Azulite, Inc.	Phototherapy devices and methods for treating truncal acne and scars
AU2020214645A1 (en)*	2019-01-31	2021-09-23	Pulsethera Corporation	Bacterialcidal methods and compositions
CN109999225B (en)*	2019-04-24	2021-06-08	温州医科大学	A kind of bone repair material and preparation method thereof
JP7405543B2 (en)*	2019-09-19	2023-12-26	オリザ油化株式会社	Oral skin care composition
KR102309402B1 (en)*	2019-12-03	2021-10-07	한국에너지기술연구원	A sheet including light-emitting material
US12433964B2 (en)	2020-05-07	2025-10-07	Purdue Research Foundation	Antiviral and antibacterial disinfection aero-solution using edible food dyes
RU2753794C1 (en)*	2021-02-04	2021-08-23	Никита Андреевич Чунихин	Method for the treatment of chronic periodontitis using the technology of transcanal laser non-pigment photoablation
IT202100014150A1 (en)*	2021-05-31	2022-12-01	Vs Ortho Societa’ A Responsabilita’ Limitata	Light-curing dental lamp
CN115054539B (en)*	2021-08-27	2024-06-18	湖南科洛克医药有限公司	Preparation process of anti-inflammatory scar-removing gel
CN115054567B (en)*	2021-08-30	2024-10-01	湖南科洛克医药有限公司	A skin wound repair gel and its use method and application
IT202200000689A1 (en)*	2022-01-18	2023-07-18	Marco Balato	USE OF DYES IN THE SELECTIVE IDENTIFICATION OF INFECTED SITES IN BIOFILM-RELATED INFECTIONS
CN115487340B (en)*	2022-10-31	2023-11-17	振德医疗用品股份有限公司	Bacterial cellulose dressing loaded with active oxygen and preparation method thereof
CN115957331B (en)*	2022-12-08	2025-07-11	沈阳药科大学	Scar removing gel and preparation method thereof

Family Cites Families (156)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA495814A (en)*		1953-09-08	H. Gorin Manuel	Antiseptic wound dressing
US2877221A (en)*	1954-03-17	1959-03-10	Pfizer & Co C	11, 14-peroxides of substituted ergostadiene compounds
US3309274A (en)	1962-07-23	1967-03-14	Brilliant Herbert	Use of fluorescent dyes in dental diagnostic methods
US3293127A (en)	1964-07-22	1966-12-20	Gold Crest Chemical Corp Inc	Arterial embalming fluid and method for embalming therewith
DE1617744A1 (en)*	1964-07-24	1970-09-10	Peter Strong & Co Inc	Cleaning agents for dentures
NL152290B (en)	1965-09-08	1977-02-15	American Cyanamid Co	PROCESS FOR PREPARING CHEMILUMINESCENT MIXTURES.
US3372125A (en)*	1965-11-15	1968-03-05	Peter Strong & Company Inc	Denture cleanser
US3595798A (en)*	1967-12-18	1971-07-27	Lever Brothers Ltd	Cleansing compositions
US3671450A (en)	1969-09-22	1972-06-20	American Cyanamid Co	Chemiluminescent compositions
US3728446A (en)*	1971-01-11	1973-04-17	Colgate Palmolive Co	Speckled dentifrice gel
FR2463613A1 (en)	1979-08-20	1981-02-27	Thorel Jean Noel	NEW COMPOSITIONS FOR THE REVELATION OF THE DENTAL PLATE
US4574097A (en)	1984-08-10	1986-03-04	Isopedix Corporation	Reinforced thixotropic gel composition
US4846165A (en)	1986-11-26	1989-07-11	Dentsply Research & Development Corp.	Wound dressing membrane
JPH01279838A (en)	1988-04-30	1989-11-10	Kiyuukiyuu Yakuhin Kogyo Kk	Lysozyme chloride-containing plaster for gingivitis and pyorrhea
US4891211A (en)*	1988-06-29	1990-01-02	Church & Dwight Co., Inc.	Stable hydrogen peroxide-releasing dentifice
EP0356868A3 (en)	1988-09-01	1991-03-20	Dentsply International, Inc.	A method of treating a tooth with adhesive dental cavity basing composition
NL8900165A (en)	1989-01-24	1990-08-16	Matthijs Cornelis Evers	WOUND POWDER.
WO1990009779A1 (en)	1989-02-28	1990-09-07	Benhuri Marc N	Method and composition for treatment of periodontal disease
JPH0383927A (en)	1989-08-25	1991-04-09	Sunstar Inc	Periodontal tissue regeneration promoter
US4992256A (en)	1989-09-27	1991-02-12	Colgate-Palmolive Company	Plaque disclosing compositions
DE4007428A1 (en)*	1990-03-09	1991-09-12	Hoechst Ag	Photopolymerisable mixt. sensitive to near UV and visible light
US5800373A (en)	1995-03-23	1998-09-01	Focal, Inc.	Initiator priming for improved adherence of gels to substrates
US5749968A (en)	1993-03-01	1998-05-12	Focal, Inc.	Device for priming for improved adherence of gels to substrates
US5705357A (en)	1994-08-29	1998-01-06	Johnson & Johnson Clinical Diagnostics, Inc.	Chemiluminescent reagent and assay using a substituted acetanilide for light generation
US5599342A (en)*	1995-01-27	1997-02-04	Candela Laser Corporation	Method for treating pigmentation abnormalities using pulsed laser radiation with an elongated cross-section and apparatus for providing same
EP0815177B1 (en)	1995-03-23	2007-08-08	Genzyme Corporation	Redox and photoinitiator systems for priming for improved adherence of gels to substrates
US6056548A (en)*	1995-04-26	2000-05-02	Ceramoptec Industries, Inc.	Hygienic dental laser photo treatment method
US5658148A (en)*	1995-04-26	1997-08-19	Ceramoptec Industries, Inc.	Dental laser brushing or cleaning device
JPH092925A (en)	1995-06-16	1997-01-07	Shiseido Co Ltd	Two agent-mixing type cosmetic
AU7245596A (en)*	1995-09-25	1997-04-17	Robert Eric Montgomery	Tooth bleaching compositions
US5713738A (en)	1995-12-12	1998-02-03	Britesmile, Inc.	Method for whitening teeth
US6541460B2 (en)*	1996-08-07	2003-04-01	George D. Petito	Method for use of hyaluronic acid in wound management
WO1998010738A1 (en)	1996-09-16	1998-03-19	The Procter & Gamble Company	Antimicrobial oral care compositions
US5913884A (en)*	1996-09-19	1999-06-22	The General Hospital Corporation	Inhibition of fibrosis by photodynamic therapy
US7390668B2 (en)*	1996-10-30	2008-06-24	Provectus Pharmatech, Inc.	Intracorporeal medicaments for photodynamic treatment of disease
US7353829B1 (en)*	1996-10-30	2008-04-08	Provectus Devicetech, Inc.	Methods and apparatus for multi-photon photo-activation of therapeutic agents
US6846182B1 (en)*	1996-11-27	2005-01-25	Jeffrey A. Sibner	Dental bleaching composition and method
WO1998023219A1 (en)	1996-11-27	1998-06-04	Sibner Jeffrey A	Dental bleaching composition and method
US8182473B2 (en)	1999-01-08	2012-05-22	Palomar Medical Technologies	Cooling system for a photocosmetic device
FR2756741B1 (en)*	1996-12-05	1999-01-08	Cird Galderma	USE OF A CHROMOPHORE IN A COMPOSITION INTENDED TO BE APPLIED TO THE SKIN BEFORE LASER TREATMENT
JPH10182390A (en)	1996-12-25	1998-07-07	Lion Corp	Oral composition
US5858332A (en)*	1997-01-10	1999-01-12	Ultradent Products, Inc.	Dental bleaching compositions with high concentrations of hydrogen peroxide
US6391283B1 (en)*	1997-01-10	2002-05-21	Ultradent Products, Inc.	Methods and apparatus for activating dental compositions
US5785527A (en)	1997-01-10	1998-07-28	Ultradent Products, Inc.	Stable light or heat activated dental bleaching compositions
EP0956280B1 (en)	1997-01-30	2002-10-30	Ciba SC Holding AG	Non-volatile phenylglyoxalic esters
US6305936B1 (en)	1997-02-19	2001-10-23	Ultradent Products, Inc.	Polymerizable isolation barriers with reduced polymerization strength and methods for forming and using such barriers
KR100493539B1 (en)*	1997-02-24	2005-09-02	가부시키가이샤 구라레	Antimicrobial caries-detecting composition
US5922331A (en)*	1997-03-26	1999-07-13	Chanel, Inc.	Skin cream composition
JPH10330235A (en)	1997-06-02	1998-12-15	Lion Corp	Denture cleaner
US6108850A (en)*	1997-06-03	2000-08-29	Mclaughlin; Gerald	Accelerated method and instrumentation for whitening teeth
US6161544A (en)	1998-01-28	2000-12-19	Keratoform, Inc.	Methods for accelerated orthokeratology
KR20010040958A (en)	1998-02-13	2001-05-15	브라이트스마일 인코포레이티드	Light-activated tooth whitening composition and method of using same
US6162055A (en)	1998-02-13	2000-12-19	Britesmile, Inc.	Light activated tooth whitening composition and method of using same
US20030198605A1 (en)*	1998-02-13	2003-10-23	Montgomery R. Eric	Light-activated tooth whitening composition and method of using same
US5977199A (en)	1998-02-17	1999-11-02	The Kerr Corporation	Composition, delivery system therefor, and method for making temporary crowns and bridges
US6149895A (en)*	1998-02-17	2000-11-21	Kreativ, Inc	Dental bleaching compositions, kits & methods
WO1999049823A1 (en)	1998-03-30	1999-10-07	Fibermark, Inc.	Light-activated antimicrobial polymeric materials
US6036493A (en)*	1998-07-23	2000-03-14	Ad Dent Inc.	Dental bleaching system and method
US7648695B2 (en)*	1998-08-06	2010-01-19	Provectus Pharmatech, Inc.	Medicaments for chemotherapeutic treatment of disease
JP4199333B2 (en)	1998-08-07	2008-12-17	宇部マテリアルズ株式会社	Dentifrice composition
US6887260B1 (en)	1998-11-30	2005-05-03	Light Bioscience, Llc	Method and apparatus for acne treatment
US6030222A (en)*	1998-12-01	2000-02-29	Tarver; Jeanna G.	Dye compositions and methods for whitening teeth using same
US6183773B1 (en)	1999-01-04	2001-02-06	The General Hospital Corporation	Targeting of sebaceous follicles as a treatment of sebaceous gland disorders
US6423697B1 (en)	1999-01-14	2002-07-23	Mark Friedman	Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache, facial pain, and cervical-muscle spasm
US6420455B1 (en)*	1999-06-18	2002-07-16	3M Innovative Properties Company	Antimicrobial composition containing photosensitizers articles, and methods of use
IT1306679B1 (en)	1999-06-29	2001-10-02	Fidia Advanced Biopolymers Srl	USE OF HYALURONIC ACID DERIVATIVES FOR THE PREPARATION OF PHARMACEUTICAL AND BIOMATERIAL COMPOSITIONS FOR THE PREVENTION OF
US6365134B1 (en)*	1999-07-07	2002-04-02	Scientific Pharmaceuticals, Inc.	Process and composition for high efficacy teeth whitening
NL1012696C2 (en)	1999-07-23	2001-01-24	Berg Electronics Mfg	Plug or socket for use in a power connector.
CA2380805C (en)*	1999-08-13	2010-04-13	Photogen, Inc.	Improved topical medicaments and methods for photodynamic treatment of disease
US7220438B2 (en)*	1999-09-23	2007-05-22	Asac Compañia de Biotecnologia	Pharmacological activities of Curcuma longa extracts
US6475498B1 (en)	1999-12-08	2002-11-05	The Procter & Gamble Company	Method to inhibit tartar and stain using denture adhesive compositions
MXPA02005750A (en)	1999-12-08	2002-09-18	Procter & Gamble	Tartar control denture adhesive compositions.
US6905672B2 (en)*	1999-12-08	2005-06-14	The Procter & Gamble Company	Compositions and methods to inhibit tartar and microbes using denture adhesive compositions with colorants
US6475497B1 (en)*	1999-12-08	2002-11-05	The Procter & Gamble Company	Tartar control denture adhesive compositions
US6444725B1 (en)*	2000-01-21	2002-09-03	3M Innovative Properties Company	Color-changing dental compositions
JP4271339B2 (en)*	2000-03-31	2009-06-03	富士フイルム株式会社	Manufacturing method of thermal head
US6267976B1 (en)*	2000-04-14	2001-07-31	Gojo Industries, Inc.	Skin cleanser with photosensitive dye
US6800671B1 (en)	2000-04-21	2004-10-05	Britesmile, Inc.	Low peak exotherm curable compositions
AU2000272625B2 (en)	2000-09-14	2006-06-29	High Tech Laser	Method and composition for dental bleaching
US6528555B1 (en)*	2000-10-12	2003-03-04	3M Innovative Properties Company	Adhesive for use in the oral environment having color-changing capabilities
DE10056114A1 (en)*	2000-11-04	2002-05-29	Wolfgang Malodobry	Scar-free tattoo removal
US6485709B2 (en)	2001-01-23	2002-11-26	Addent Inc.	Dental bleaching gel composition, activator system and method for activating a dental bleaching gel
JP2002233612A (en)	2001-02-07	2002-08-20	Daito Giken:Kk	Gable table
JP2002293747A (en)*	2001-03-29	2002-10-09	Jinen:Kk	Skin preparation for external use
CA2447302C (en)	2001-05-01	2008-07-29	A.V. Topchiev Institute Of Petrochemical Synthesis	Two-phase, water-absorbent bioadhesive composition
US6676816B2 (en)	2001-05-11	2004-01-13	Therasense, Inc.	Transition metal complexes with (pyridyl)imidazole ligands and sensors using said complexes
ITMI20011315A1 (en)	2001-06-21	2002-12-21	Herbariorum Medicaminum Offici	COMPOSITION FOR ANTI-PLATE TOOTHPASTE PASTE WITH PLATE DETECTOR
US20030009158A1 (en)	2001-07-09	2003-01-09	Perricone Nicholas V.	Skin treatments using blue and violet light
US6558653B2 (en)*	2001-09-19	2003-05-06	Scot N. Andersen	Methods for treating periodontal disease
US7329274B2 (en)*	2001-11-29	2008-02-12	Palomar Medical Technologies, Inc.	Conforming oral phototherapy applicator
FR2833841B1 (en)*	2001-12-21	2005-07-22	Galderma Res & Dev	GEL COMPRISING AT LEAST ONE RETINOID AND BENZOYL PEROXIDE
CA2473924A1 (en)	2002-01-23	2003-07-31	Light Sciences Corporation	Systems and methods for photodynamic therapy
US7081128B2 (en)	2002-03-04	2006-07-25	Hart Barry M	Phototherapy device and method of use
US6960079B2 (en)*	2002-04-18	2005-11-01	3M Innovative Properties Company	Orthodontic adhesives and appliances including an adhesive on the base of the appliance
AU2003273155A1 (en)	2002-05-07	2003-12-12	Atair Aerospace, Inc.	Pneumatic riser release
US6949240B2 (en)	2002-05-23	2005-09-27	The Procter & Gamble Company	Tooth whitening products
US6786274B2 (en)	2002-09-12	2004-09-07	York International Corporation	Heat exchanger fin having canted lances
US20050098766A1 (en)	2002-09-19	2005-05-12	Watson David L.Jr.	Chemiluminescent processes and systems
GB0222091D0 (en)	2002-09-24	2002-10-30	Boots Co Plc	Dental compositions and methods
AU2003285887B2 (en)*	2002-10-11	2008-09-11	Novocell, Inc.	Implantation of encapsulated biological materials for treating diseases
WO2004052238A2 (en)	2002-12-10	2004-06-24	University Of Florida	Phototherapy bandage
CN1506042A (en)*	2002-12-11	2004-06-23	苏加璐	Method and composition for improving skin state using compound from fetal cell and tissue
WO2004061222A1 (en)	2003-01-02	2004-07-22	Metso Paper, Inc.	Multiroll calender
US7157502B2 (en)	2003-02-19	2007-01-02	Pulpdent Corporation	Polymerizable dental barrier material
WO2004081222A2 (en)	2003-03-14	2004-09-23	Sol-Gel Technologies Ltd.	Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
US20040191330A1 (en)*	2003-03-31	2004-09-30	Keefe Candace R.	Daily skin care regimen
US7114953B1 (en)	2003-04-25	2006-10-03	Wagner Eugene C	Tooth whitening appliance having membrane covered applicator
JP2003339875A (en)	2003-06-16	2003-12-02	Hirokatsu Kimura	Tatoo eliminating device
AU2004253463B2 (en)	2003-06-16	2010-12-09	Loma Linda University Medical Center	Deployable multifunctional hemostatic agent
GB0314210D0 (en)*	2003-06-18	2003-07-23	Unilever Plc	Laundry treatment compositions
KR100960687B1 (en)	2003-06-24	2010-06-01	엘지디스플레이 주식회사	Etch solution for collective etching of a double metal layer containing copper (or copper alloy layer)
JP4219756B2 (en)	2003-07-23	2009-02-04	京セラ株式会社	Mobile terminal device
BRPI0413131A (en)	2003-07-31	2007-04-10	Sol Gel Technologies Ltd	micro capsules loaded with active ingredients and a method for their preparation
US7148066B2 (en)*	2003-08-01	2006-12-12	Glotell Products, Inc.	Dye solutions for use in methods to detect the prior evaporation of anhydrous ammonia and the production of illict drugs
US8795693B2 (en)*	2003-08-04	2014-08-05	Foamix Ltd.	Compositions with modulating agents
US20050042712A1 (en)	2003-08-22	2005-02-24	Advanced Medical Optics, Inc.	Methods, compositions and instruments to predict antimicrobial or preservative activity
US20050049228A1 (en)*	2003-09-02	2005-03-03	Ceramoptec Industries Inc.	Antimicrobial photodynamic therapy compound and method of use
US20050059731A1 (en)*	2003-09-16	2005-03-17	Ceramoptec Industries, Inc.	Erythrosin-based antimicrobial photodynamic therapy compound and its use
CA2540621A1 (en)	2003-11-19	2005-06-09	Barnes-Jewish Hospital	Enhanced drug delivery
US20070244195A1 (en)	2004-05-18	2007-10-18	Burkhart Craig N	Treatment methods with peroxides and tertiary amines
EP1749532B1 (en)	2004-05-21	2014-04-23	Tottori University	Drug for remedy or treatment of wound
US20050281890A1 (en)*	2004-06-18	2005-12-22	San Chandan K	Methods and compositions for wound healing
AU2005269869B2 (en)	2004-07-08	2011-12-01	3M Innovative Properties Company	Dental methods, compositions, and kits including acid-sensitive dyes
GB0420888D0 (en)*	2004-09-20	2004-10-20	Photopharmica Ltd	Compounds and uses
CA2486475A1 (en)	2004-11-02	2006-05-02	John Kennedy	Method of treating microorganisms in the oral cavity
EP1809382B1 (en)	2004-11-09	2010-11-03	Discus Dental, LLC	Two-component dental whitening compositions
WO2006072243A1 (en)	2005-01-03	2006-07-13	Novozymes Biopolymer A/S	Hyaluronic acid fraction with moisturizing and anti-wrinkle properties
WO2006089028A2 (en)*	2005-02-15	2006-08-24	Lab39, Llc	Foaming compositions and methods
EP1733762A1 (en)	2005-05-25	2006-12-20	3M Espe AG	Dental composition for detection of carious tissue, detection method
US20090285766A1 (en)*	2005-06-13	2009-11-19	National University Of Singapore	Photosensitising Composition and Uses Thereof
WO2007001926A2 (en)*	2005-06-24	2007-01-04	Hyperbranch Medical Technology, Inc.	Low-swelling hydrogel sealants for wound repair
CA2632183A1 (en)*	2005-08-25	2007-03-01	Philip R. Houle	Treatment systems for delivery of sensitizer solutions
US8128973B2 (en)*	2005-09-07	2012-03-06	Noreen Mulvanerty	Medicated skin care preparation for promoting wound healing
US20070092469A1 (en)*	2005-10-26	2007-04-26	Eric Jacobs	Topically applied Glucosamine Sulfate and all its related, precursor, and derivative compounds significantly increases the skin's natural produciton of hyaluronic acid for the rejuvenation of healthier younger-looking skin; while PhosphatidylCholine is required to replace its deficiency caused by topical Dimethylaminoethanol (DMAE)
EP1779891A1 (en)*	2005-10-28	2007-05-02	Abdula Kurkayev	Method of activating a photosensitizer
CA2966261A1 (en)*	2005-11-09	2007-07-19	Klox Technologies Inc.	Teeth whitening compositions and methods
US8999933B2 (en)*	2006-01-18	2015-04-07	Biolitec Pharma Marketing Ltd	Photodynamic cosmetic procedure and healing method
AR059155A1 (en)	2006-01-23	2008-03-12	Procter & Gamble	COMPOSITIONS THAT INCLUDE ENZYMES AND PHOTOBLANKERS
US8454991B2 (en)*	2006-07-24	2013-06-04	Quest Pharmatech Inc.	Method and device for photodynamic therapy
WO2008013962A2 (en)	2006-07-28	2008-01-31	Ceramoptec Industries, Inc.	Method and mixture for in-vivo photochemical cross-linking of collagen
WO2008052081A2 (en)	2006-10-24	2008-05-02	California Institute Of Technology	Photochemical therapy to affect mechanical and/or chemical properties of body tissue
US20080108681A1 (en)*	2006-10-27	2008-05-08	Access Business Group International Llc	Use of allantoin as a pro-collagen synthesis agent in cosmetic compositions
US20100266989A1 (en)	2006-11-09	2010-10-21	Klox Technologies Inc.	Teeth whitening compositions and methods
US20080113037A1 (en)*	2006-11-10	2008-05-15	Green Barbara A	Topical Compositions Comprising Polyhydroxy Acids and/or Lactones for Improved Cutaneous Effects of Oxidative Therapeutic Drugs
US9101671B2 (en)	2007-01-03	2015-08-11	Sanford-Burnham Medical Research Institute	Methods and compositions related to clot binding compounds
WO2008096182A1 (en)	2007-02-09	2008-08-14	Klox Technologies Inc.	Photopolymerization material for gums isolation
WO2009089346A2 (en)	2008-01-08	2009-07-16	Quick-Med Technologies, Inc.	Disinfectant alcohol-soluble quaternary ammonium polymers
WO2009089345A2 (en)	2008-01-08	2009-07-16	Blazetrak, Llc	Review managment system for audition portfolios
DK2365829T3 (en)*	2008-11-07	2017-07-31	Klox Tech Inc	COMBINATION OF AN OXIDANT AND PHOTO ACTIVATOR FOR HEALING OF WOES
MX346003B (en)*	2009-07-17	2017-03-01	Klox Tech Inc *	Antibacterial oral composition.
EA201691172A1 (en)	2009-10-27	2017-08-31	Клокс Текнолоджиз Инк.	DEVICE FOR PERSONAL USE IN PHOTOTHERAPY
GB201012217D0 (en)	2010-07-21	2010-09-08	Republic Polytechnic	Compounds for photodynamic therapy
US20130281913A1 (en)	2012-04-20	2013-10-24	Klox Technologies Inc.	Biophotonic compositions and methods for providing biophotonic treatment
US8658466B2 (en)*	2012-06-18	2014-02-25	Chipbond Technology Corporation	Semiconductor package structure and method for making the same
IN2015DN02938A (en)	2012-09-14	2015-09-18	Klox Technologies Inc
BR112015020804A2 (en)	2013-03-01	2017-07-18	Klox Tech Inc	phototherapeutic device, method and use

2009
- 2009-11-06DKDK09824315.7Tpatent/DK2365829T3/enactive
- 2009-11-06EPEP09824320.7Apatent/EP2352488B1/enactiveActive
- 2009-11-06MXMX2011004868Apatent/MX339255B/enactiveIP Right Grant
- 2009-11-06PLPL09824320Tpatent/PL2352488T3/enunknown
- 2009-11-06BRBRPI0921269-8Apatent/BRPI0921269A2/ennot_activeApplication Discontinuation
- 2009-11-06NZNZ631218Apatent/NZ631218A/ennot_activeIP Right Cessation
- 2009-11-06CNCN200980154338.XApatent/CN102256591B/enactiveActive
- 2009-11-06CACA2936527Apatent/CA2936527C/ennot_activeExpired - Fee Related
- 2009-11-06HRHRP20171022TTpatent/HRP20171022T1/enunknown
- 2009-11-06PLPL09824315Tpatent/PL2365829T3/enunknown
- 2009-11-06ESES09824320.7Tpatent/ES2618802T3/enactiveActive
- 2009-11-06CNCN201510083789.6Apatent/CN104707143B/enactiveActive
- 2009-11-06KRKR1020177035767Apatent/KR20170141807A/ennot_activeCeased
- 2009-11-06SGSG10201703078QApatent/SG10201703078QA/enunknown
- 2009-11-06CNCN201610020876.1Apatent/CN105640987B/enactiveActive
- 2009-11-06HRHRP20170343TTpatent/HRP20170343T1/enunknown
- 2009-11-06PTPT98243207Tpatent/PT2352488T/enunknown
- 2009-11-06EAEA201792479Apatent/EA201792479A3/enunknown
- 2009-11-06ESES09824315.7Tpatent/ES2632717T3/enactiveActive
- 2009-11-06CACA2742943Apatent/CA2742943C/enactiveActive
- 2009-11-06EAEA201690702Apatent/EA029534B1/ennot_activeIP Right Cessation
- 2009-11-06PTPT16199672Tpatent/PT3150210T/enunknown
- 2009-11-06PTPT98243157Tpatent/PT2365829T/enunknown
- 2009-11-06BRBRPI0920926Apatent/BRPI0920926B1/enactiveIP Right Grant
- 2009-11-06NZNZ610404Apatent/NZ610404A/ennot_activeIP Right Cessation
- 2009-11-06WOPCT/CA2009/001608patent/WO2010051636A1/enactiveApplication Filing
- 2009-11-06PLPL16199672Tpatent/PL3150210T3/enunknown
- 2009-11-06SMSM20170335Tpatent/SMT201700335T1/enunknown
- 2009-11-06KRKR1020117012317Apatent/KR101717792B1/ennot_activeExpired - Fee Related
- 2009-11-06KRKR1020177006582Apatent/KR101835047B1/ennot_activeExpired - Fee Related
- 2009-11-06DKDK09824320.7Tpatent/DK2352488T3/enactive
- 2009-11-06HUHUE16199672Apatent/HUE045950T2/enunknown
- 2009-11-06CACA2742942Apatent/CA2742942C/ennot_activeExpired - Fee Related
- 2009-11-06KRKR1020187005705Apatent/KR20180023070A/ennot_activeCeased
- 2009-11-06JPJP2011534980Apatent/JP5478631B2/ennot_activeExpired - Fee Related
- 2009-11-06EAEA201300898Apatent/EA026962B1/ennot_activeIP Right Cessation
- 2009-11-06MXMX2016001890Apatent/MX376877B/enunknown
- 2009-11-06LTLTEP09824315.7Tpatent/LT2365829T/enunknown
- 2009-11-06EAEA201170651Apatent/EA024725B1/ennot_activeIP Right Cessation
- 2009-11-06SGSG10201703071YApatent/SG10201703071YA/enunknown
- 2009-11-06USUS13/127,445patent/US8658219B2/enactiveActive
- 2009-11-06SISI200931696Tpatent/SI2365829T1/enunknown
- 2009-11-06JPJP2011534983Apatent/JP5478632B2/ennot_activeExpired - Fee Related
- 2009-11-06SMSM20170155Tpatent/SMT201700155T1/enunknown
- 2009-11-06LTLTEP09824320.7Tpatent/LT2352488T/enunknown
- 2009-11-06HUHUE09824320Apatent/HUE032192T2/enunknown
- 2009-11-06DKDK16199672.3Tpatent/DK3150210T3/enactive
- 2009-11-06NZNZ592650Apatent/NZ592650A/enunknown
- 2009-11-06KRKR1020117012318Apatent/KR101810148B1/ennot_activeExpired - Fee Related
- 2009-11-06USUS13/127,435patent/US8632822B2/enactiveActive
- 2009-11-06MXMX2011004865Apatent/MX337084B/enactiveIP Right Grant
- 2009-11-06ESES16199672Tpatent/ES2743314T3/enactiveActive
- 2009-11-06NZNZ717641Apatent/NZ717641A/ennot_activeIP Right Cessation
- 2009-11-06EPEP16199672.3Apatent/EP3150210B1/enactiveActive
- 2009-11-06AUAU2009311239Apatent/AU2009311239B2/enactiveActive
- 2009-11-06EAEA201170650Apatent/EA024827B1/ennot_activeIP Right Cessation
- 2009-11-06AUAU2009311234Apatent/AU2009311234B2/enactiveActive
- 2009-11-06WOPCT/CA2009/001615patent/WO2010051641A1/enactiveApplication Filing
- 2009-11-06EPEP09824315.7Apatent/EP2365829B1/enactiveActive
- 2009-11-06SISI200931629Apatent/SI2352488T1/enunknown
- 2009-11-06CACA2935819Apatent/CA2935819A1/ennot_activeAbandoned
- 2009-11-06NZNZ592651Apatent/NZ592651A/ennot_activeIP Right Cessation
- 2009-11-06CNCN200980154337.5Apatent/CN102300587B/enactiveActive
- 2009-11-06EPEP17164101.2Apatent/EP3205355A1/ennot_activeWithdrawn
2011
- 2011-04-28ILIL212559Apatent/IL212559A/enactiveIP Right Grant
- 2011-04-28ILIL212560Apatent/IL212560A/enactiveIP Right Grant
2013
- 2013-02-19USUS13/770,907patent/US8637086B2/enactiveActive
- 2013-09-18JPJP2013193123Apatent/JP5815622B2/ennot_activeExpired - Fee Related
- 2013-09-18JPJP2013193133Apatent/JP5827654B2/ennot_activeExpired - Fee Related
- 2013-12-20USUS14/137,599patent/US8911791B2/enactiveActive
- 2013-12-20USUS14/137,736patent/US8974833B2/enactiveActive
- 2013-12-20USUS14/137,525patent/US8986745B2/ennot_activeExpired - Fee Related
2014
- 2014-11-11USUS14/538,482patent/US9597349B2/enactiveActive
- 2014-11-13USUS14/540,484patent/US9375446B2/ennot_activeExpired - Fee Related
2015
- 2015-09-24JPJP2015186562Apatent/JP5996066B2/enactiveActive
- 2015-10-16JPJP2015204498Apatent/JP5996077B2/ennot_activeExpired - Fee Related
- 2015-12-15HKHK15112294.1Apatent/HK1211478A1/enunknown
2016
- 2016-05-01ILIL245427Apatent/IL245427A0/enunknown
- 2016-05-24USUS15/162,801patent/US10149985B2/enactiveActive
- 2016-08-23JPJP2016162700Apatent/JP6167213B2/ennot_activeExpired - Fee Related
- 2016-08-23JPJP2016162696Apatent/JP6166825B2/ennot_activeExpired - Fee Related
2017
- 2017-02-07USUS15/426,892patent/US10384072B2/enactiveActive
- 2017-03-09CYCY20171100304Tpatent/CY1118716T1/enunknown
- 2017-04-03ILIL251534Apatent/IL251534A0/enunknown
- 2017-06-23JPJP2017123314Apatent/JP6453388B2/ennot_activeExpired - Fee Related
- 2017-06-26JPJP2017124257Apatent/JP2017160277A/enactivePending
- 2017-07-11CYCY20171100735Tpatent/CY1119174T1/enunknown
2018
- 2018-12-05USUS16/210,034patent/US10485986B2/ennot_activeExpired - Fee Related
2019
- 2019-08-07HRHRP20191416patent/HRP20191416T1/enunknown
- 2019-08-09USUS16/536,957patent/US10758744B2/enactiveActive
- 2019-11-25USUS16/693,840patent/US11020609B2/ennot_activeExpired - Fee Related
2021
- 2021-05-28USUS17/333,345patent/US11691025B2/enactiveActive

Also Published As

Publication number	Publication date
US20200330783A1 (en)	2020-10-22
US20110218482A1 (en)	2011-09-08
CN102300587B (en)	2015-04-01
BRPI0920926B1 (en)	2017-04-04
LT2365829T (en)	2017-10-25
KR20170141807A (en)	2017-12-26
MX376877B (en)	2025-03-07
NZ631218A (en)	2016-03-31
JP5827654B2 (en)	2015-12-02
CA2742942C (en)	2016-09-06
HUE045950T2 (en)	2020-01-28
CN105640987A (en)	2016-06-08
JP2016193950A (en)	2016-11-17
WO2010051636A1 (en)	2010-05-14
CN102256591A (en)	2011-11-23
US8637086B2 (en)	2014-01-28
CA2742942A1 (en)	2010-05-14
EA024725B1 (en)	2016-10-31
ES2743314T3 (en)	2020-02-18
LT2352488T (en)	2017-05-25
MX339255B (en)	2016-05-18
HRP20170343T1 (en)	2017-06-16
JP5996077B2 (en)	2016-09-21
US9375446B2 (en)	2016-06-28
JP2013253110A (en)	2013-12-19
BRPI0920926A2 (en)	2016-09-20
JP2016020386A (en)	2016-02-04
DK2352488T3 (en)	2017-03-27
AU2009311234A1 (en)	2010-05-14
US10758744B2 (en)	2020-09-01
HRP20191416T1 (en)	2019-11-15
US20170049802A1 (en)	2017-02-23
NZ592651A (en)	2013-05-31
US20130165845A1 (en)	2013-06-27
ES2632717T3 (en)	2017-09-15
PT2365829T (en)	2017-07-17
PL3150210T3 (en)	2019-12-31
NZ610404A (en)	2014-11-28
KR20170031259A (en)	2017-03-20
MX2011004865A (en)	2011-10-17
US10485986B2 (en)	2019-11-26
SMT201700155T1 (en)	2017-05-08
CA2936527A1 (en)	2010-05-14
EA201170651A1 (en)	2011-12-30
JP2012508189A (en)	2012-04-05
IL212559A0 (en)	2011-06-30
SMT201700335T1 (en)	2017-09-07
MX337084B (en)	2016-02-10
CA2935819A1 (en)	2010-05-14
US9597349B2 (en)	2017-03-21
EA201170650A1 (en)	2011-12-30
EA201792479A2 (en)	2018-04-30
EA026962B1 (en)	2017-06-30
EP3150210A1 (en)	2017-04-05
HRP20171022T1 (en)	2017-09-22
AU2009311239B2 (en)	2012-11-15
US10384072B2 (en)	2019-08-20
EA201300898A1 (en)	2014-04-30
IL245427A0 (en)	2016-06-30
JP5478632B2 (en)	2014-04-23
JP2013253109A (en)	2013-12-19
JP2017160271A (en)	2017-09-14
US8911791B2 (en)	2014-12-16
JP2016006120A (en)	2016-01-14
CN105640987B (en)	2020-04-14
JP5478631B2 (en)	2014-04-23
EP2365829A1 (en)	2011-09-21
IL212560A0 (en)	2011-06-30
CN104707143A (en)	2015-06-17
IL212560A (en)	2017-04-30
CY1118716T1 (en)	2017-07-12
US8658219B2 (en)	2014-02-25
US10149985B2 (en)	2018-12-11
PL2352488T3 (en)	2017-07-31
EP3150210B1 (en)	2019-05-22
JP5996066B2 (en)	2016-09-21
KR20180023070A (en)	2018-03-06
EP2365829A4 (en)	2011-10-19
JP2012508190A (en)	2012-04-05
JP2017160277A (en)	2017-09-14
KR101835047B1 (en)	2018-03-08
PT3150210T (en)	2019-09-04
HK1225610A1 (en)	2017-09-15
US20190143137A1 (en)	2019-05-16
DK3150210T3 (en)	2019-09-02
US20170143989A1 (en)	2017-05-25
EP2352488A4 (en)	2012-04-25
SI2365829T1 (en)	2017-10-30
US20210283417A1 (en)	2021-09-16
CN104707143B (en)	2018-04-27
US20190366113A1 (en)	2019-12-05
ES2618802T3 (en)	2017-06-22
PT2352488T (en)	2017-03-20
EA201690702A1 (en)	2016-11-30
CA2936527C (en)	2022-05-17
JP6166825B2 (en)	2017-07-19
PL2365829T3 (en)	2018-01-31
SG10201703078QA (en)	2017-05-30
US11020609B2 (en)	2021-06-01
EP2352488B1 (en)	2017-01-04
US11691025B2 (en)	2023-07-04
EP2365829B1 (en)	2017-05-24
US20140221901A1 (en)	2014-08-07
NZ592650A (en)	2013-05-31
US20110224599A1 (en)	2011-09-15
EP2352488A1 (en)	2011-08-10
US8974833B2 (en)	2015-03-10
US20140221903A1 (en)	2014-08-07
EA201792479A3 (en)	2018-09-28
US20150065453A1 (en)	2015-03-05
IL212559A (en)	2016-06-30
US20140221902A1 (en)	2014-08-07
AU2009311234B2 (en)	2013-05-02
JP5815622B2 (en)	2015-11-17
CY1119174T1 (en)	2018-02-14
IL251534A0 (en)	2017-05-29
US8632822B2 (en)	2014-01-21
CN102256591B (en)	2016-02-10
KR101717792B1 (en)	2017-03-17
MX2011004868A (en)	2011-10-17
BRPI0921269A2 (en)	2018-10-16
JP6167213B2 (en)	2017-07-19
KR20110094017A (en)	2011-08-19
JP2016193951A (en)	2016-11-17
EA029534B1 (en)	2018-04-30
KR20110090983A (en)	2011-08-10
AU2009311239A1 (en)	2010-05-14
US20150306131A1 (en)	2015-10-29
JP6453388B2 (en)	2019-01-16
DK2365829T3 (en)	2017-07-31
HUE032192T2 (en)	2017-09-28
CA2742943C (en)	2016-09-13
HK1211478A1 (en)	2016-05-27
US8986745B2 (en)	2015-03-24
CN102300587A (en)	2011-12-28
WO2010051641A1 (en)	2010-05-14
KR101810148B1 (en)	2017-12-19
SI2352488T1 (en)	2017-07-31
EP3205355A1 (en)	2017-08-16
CA2742943A1 (en)	2010-05-14
NZ717641A (en)	2017-09-29
EA024827B1 (en)	2016-10-31

Publication	Publication Date	Title
SG10201703071YA (en)	2017-06-29	Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin
PL3498262T3 (en)	2022-02-07	Hyaluronic acid injectable gel
AP2010005377A0 (en)	2010-08-31	Beta-lactones as antibacterial agents.
HUE039941T2 (en)	2019-02-28	High-reflection glazing
GB0800145D0 (en)	2008-02-13	Skincare treatment
EP2265740A4 (en)	2016-11-16	Aluminum treatment composition
IL207593A0 (en)	2010-12-30	Blood substitute solution
GB0802201D0 (en)	2008-03-12	Treatment system
GB0822077D0 (en)	2009-01-07	Novel treatments
EP2265112A4 (en)	2011-08-03	Timber treatment unit
PL2321306T3 (en)	2012-06-29	3-cyanopyrrolidinyl-phenyl-oxazolidinones as antibacterial agents
GB0823273D0 (en)	2009-01-28	Treatment system
AU2008100685A4 (en)	2008-08-28	Medical Lines Stay
GB2465211B (en)	2013-09-25	Treatment Solution
AU2008903020A0 (en)	2008-06-26	Treatment
GB0811637D0 (en)	2008-07-30	Hyaluronic acid crtogel
AU2008904734A0 (en)	2008-10-02	Solar Skin
AU2008905239A0 (en)	2008-10-30	Skin Treatment Formulation
GB0810535D0 (en)	2008-07-16	Catalyst treatment
AU2008902835A0 (en)	2008-06-19	Tribal - a skin care range
AU2008901333A0 (en)	2008-04-03	Electrolytic Water Treatment
AU2008900052A0 (en)	2008-01-24	Treatment for dermatological conditions
AU2008902587A0 (en)	2008-06-05	Treatment for dermatological conditions
AU2008901294A0 (en)	2008-04-03	Anti-microbial agent
AU2008900432A0 (en)	2008-02-14	Tissue specific expression

Movatterモバイル変換

SG10201703071YA - Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (1)

Publications (1)

Family

ID=42152429

Family Applications (2)

Family Applications Before (1)

Country Status (25)

Families Citing this family (76)

Family Cites Families (156)

Also Published As

Similar Documents